UK markets closed

Astellas Pharma Inc. (ALPMF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
9.520.00 (0.00%)
As of 03:37PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2025)Next year (2026)
No. of analysts2166
Avg. Estimate0.080.140.390.58
Low estimate0.070.140.150.37
High estimate0.10.140.50.74
Year ago EPS0.12-0.010.060.39
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2025)Next year (2026)
No. of analysts2166
Avg. Estimate2.63M2.81M10.7M11.26M
Low estimate2.55M2.81M10.06M10.24M
High estimate2.71M2.81M11M11.72M
Year ago sales2.38M2.49M10.17M10.7M
Sales growth (year/est)10.60%13.00%5.30%5.20%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS0.20.190.110.02
Actual EPS0.12-0.010.07-0.12
Difference-0.08-0.2-0.04-0.14
Surprise %-40.00%-105.30%-36.40%-700.00%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2025)Next year (2026)
Current estimate0.080.140.390.58
7 days ago0.1900.470.71
30 days ago0.1900.630.91
60 days ago0.1900.630.92
90 days ago0.200.741.05
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2025)Next year (2026)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/A11
Growth estimatesALPMFIndustrySector(s)S&P 500
Current qtr.-33.30%N/AN/AN/A
Next qtr.1,500.00%N/AN/AN/A
Current year550.00%N/AN/AN/A
Next year48.70%N/AN/AN/A
Next 5 years (per annum)0.11%N/AN/AN/A
Past 5 years (per annum)-6.56%N/AN/AN/A